4 Results for "

PROTAC strategy

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PROTAC strategy" in MCE Product Catalog:

Cat. No.: HY-W040270
CAS No.: 928292-69-7
Target:  

PROTAC Linkers

Research Areas:  

Cancer

Amino-PEG10-amine, a PEG-based PROTAC linker used to combine two mono diethylstilbestrol (DES)-based ligands, provides an alternative strategy for preparing more selective and active ER antagonists for endocrine therapy of breast cancer .
loading...
    loading...
Cat. No.: HY-146422
CAS No.: 2409793-36-6
Target:  

PROTACs EGFR Apoptosis

Research Areas:  

Cancer

PROTAC EGFR degrader 5 (Compound 10), a PROTAC EGFR degrader, potently degrades EGFR Del19 in HCC827 cells with the DC50 of 34.8 nM. PROTAC EGFR degrader 5 significantly induces the apoptosis of HCC827 cells and arrest the cells in G1 phase .
loading...
    loading...
Cat. No.: HY-130411
CAS No.: 479200-82-3
Purity:  ≥95.0%
Target:  

PROTAC Linkers

Research Areas:  

Cancer

Amino-PEG11-amine, a PEG-based (12 units) PROTAC linker used to combine two mono diethylstilbestrol (DES)-based ligands, provides an alternative strategy for preparing more selective and active ER antagonists for endocrine therapy of breast cancer .
loading...
    loading...
Cat. No.: HY-L137
113 compounds

Targeted protein degradation(TPD) is a novel and promising approach to new drug discovery and development. It shows great potential for treating diseases with “undruggable” pathogenic protein targets and for overcoming drug resistance. Molecular glues and PROTACs are both targeted protein degraders that have attracted the most attention.

Molecular glues are small molecular degraders that mainly induce novel interaction between an E3 ligase and a target protein to form a ternary complex, leading to protein ubiquitination and subsequent proteasome degradation. Compared with PROTACs, molecular glues generally possess more favorable drug-like properties, such as lower MW, higher cell permeability, and better oral absorption. Molecular glues are emerging as a promising new therapeutic strategy.

MCE supplies a unique collection of 113 molecular glues which target various proteins. MCE Molecular Glue Compound Library is a useful tool to conduct scientific research and disease mechanism study.